Recombinant Human MAL Protein，His

MAL (Myelin and Lysosomal Protein) is a protein primarily associated with the membrane of myelin sheaths in the central nervous system and is crucial for maintaining myelin integrity and function. Research into MAL recombinant proteins has gained significant attention due to the protein's potential involvement in various neurodegenerative diseases and demyelinating conditions, such as multiple sclerosis and leukodystrophies. Understanding the structure-function relationships of MAL and its signaling pathways can provide insight into its role in myelination and neuronal health. Recent studies have focused on developing recombinant MAL for functional assays, facilitating investigations into its interactions with other myelin-associated proteins and lipids. Furthermore, the expression of MAL in non-neuronal cell types has opened avenues for exploring its broader biological implications. By engineering MAL to study its properties and therapeutic potential, researchers aim to unveil novel strategies for treating neurological disorders characterized by myelin sheath degradation. This line of research ultimately seeks to contribute to the understanding of central nervous system pathology and the development of regenerative therapies that can restore myelin and improve neuronal function. The advancement of MAL recombinant protein studies represents a promising frontier in neuroscience, offering hope for new interventions in demyelinating diseases.